Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Nov 5;297(6657):1155–1159. doi: 10.1136/bmj.297.6657.1155

Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.

J K Cruickshank 1, N M Anderson 1, J Wadsworth 1, S M Young 1, E Jepson 1
PMCID: PMC1835009  PMID: 3144329

Abstract

STUDY OBJECTIVE--To compare responses of blood pressure to the calcium antagonist verapamil and the beta blocker metoprolol in black compared with white diabetics with hypertension and to monitor urinary albumin excretion in relation to fall in blood pressure. DESIGN--Double blind, placebo controlled, random order crossover trial with four week placebo run in period and two six week active phases separated by a two week placebo washout period. SETTING--Outpatient department of a general hospital in a multiethnic health department. Patients--Diabetic patients with hypertension. Four dropped out before randomisation; 25 black and 14 white patients completed the trial. INTERVENTIONS--Patients given slow release verapamil 120 mg or 240 mg twice daily with placebo or metoprolol 50 mg or 100 mg twice daily with placebo. Treatment for diabetes (diet alone or with oral hypoglycaemic drugs) remained unchanged. END POINT--Comparison of changes in blood pressure in the two groups taking both drugs. MEASUREMENTS AND MAIN RESULTS--Metoprolol had little effect on blood pressure in black patients (mean fall 4.0 mm Hg systolic (95% confidence interval -2.5 to 10.4 mm Hg), 4.3 mm Hg diastolic (-0.8 to 9.5)) but more effect in white patients (mean falls 13.4 mm Hg (0.1 to 26.7) and 10.6 mm Hg (4.5 to 16.7) respectively). Verapamil was more effective in both groups, with mean falls of 8.8 mm Hg (2.4 to 15.0) and 8.1 mm Hg (5.0 to 11.2) in black patients and 19.1 mm Hg (5.4 to 32.9) and 11.4 mm Hg (0.9 to 22.0) in white patients. Heart fate fell significantly in black patients taking metoprolol, which suggested compliance with treatment. Metabolic variables were unaltered by either treatment. Plasma renin activity was low in both groups after metoprolol treatment, but change in blood pressure could not be predicted from baseline plasma renin activity. Urinary albumin:creatinine ratio was independently related to baseline blood pressure but not significantly changed by treatment. CONCLUSIONS--beta Blockers alone are not effective in treating hypertension in black diabetics. Verapamil is effective but less so than in white patients. As yet no ideal monotherapy exists for hypertension in black patients.

Full text

PDF
1155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson D. E., Röjdmark S. Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus. Acta Med Scand. 1981;210(1-2):27–33. doi: 10.1111/j.0954-6820.1981.tb09771.x. [DOI] [PubMed] [Google Scholar]
  2. Beckles G. L., Miller G. J., Kirkwood B. R., Alexis S. D., Carson D. C., Byam N. T. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet. 1986 Jun 7;1(8493):1298–1301. doi: 10.1016/s0140-6736(86)91221-3. [DOI] [PubMed] [Google Scholar]
  3. Berenson G. S., Voors A. W., Webber L. S., Dalferes E. R., Jr, Harsha D. W. Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study. Metabolism. 1979 Dec;28(12):1218–1228. doi: 10.1016/0026-0495(79)90134-3. [DOI] [PubMed] [Google Scholar]
  4. Björck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):471–474. doi: 10.1136/bmj.293.6545.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cruickshank J. K., Alleyne S. A. Black West Indian and matched white diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease. Diabetes Care. 1987 Mar-Apr;10(2):170–179. doi: 10.2337/diacare.10.2.170. [DOI] [PubMed] [Google Scholar]
  6. Cruickshank J. K., Beevers D. G., Osbourne V. L., Haynes R. A., Corlett J. C., Selby S. Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. Br Med J. 1980 Oct 25;281(6248):1108–1108. doi: 10.1136/bmj.281.6248.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cruickshank J. K., Jackson S. H., Beevers D. G., Bannan L. T., Beevers M., Stewart V. L. Similarity of blood pressure in blacks, whites and Asians in England: the Birmingham Factory Study. J Hypertens. 1985 Aug;3(4):365–371. doi: 10.1097/00004872-198508000-00009. [DOI] [PubMed] [Google Scholar]
  8. Drury P. L. Diabetes and arterial hypertension. Diabetologia. 1983 Jan;24(1):1–9. doi: 10.1007/BF00275938. [DOI] [PubMed] [Google Scholar]
  9. Freis E. D., Materson B. J., Flamenbaum V. Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system. Am J Med. 1983 Jun;74(6):1029–1041. doi: 10.1016/0002-9343(83)90812-4. [DOI] [PubMed] [Google Scholar]
  10. Grell G. A., Alleyne G. A., Robinson H. M., Anderson M. Treatment of Jamaican hypertensives with atenolol and chlorthalidone. West Indian Med J. 1981 Sep;30(3):124–128. [PubMed] [Google Scholar]
  11. Haines A. P., Booroff A., Goldenberg E., Morgan P., Singh M., Wallace P. Blood pressure, smoking, obesity and alcohol consumption in black and white patients in general practice. J Hum Hypertens. 1987 Jun;1(1):39–46. [PubMed] [Google Scholar]
  12. Hommel E., Parving H. H., Mathiesen E., Edsberg B., Damkjaer Nielsen M., Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):467–470. doi: 10.1136/bmj.293.6545.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hostetter T. H., Rennke H. G., Brenner B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982 Mar;72(3):375–380. doi: 10.1016/0002-9343(82)90490-9. [DOI] [PubMed] [Google Scholar]
  14. Luft F. C., Grim C. E., Fineberg N., Weinberger M. C. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation. 1979 Apr;59(4):643–650. doi: 10.1161/01.cir.59.4.643. [DOI] [PubMed] [Google Scholar]
  15. Massie B., MacCarthy E. P., Ramanathan K. B., Weiss R. J., Anderson M., Eidelson B. A., Labreche D. G., Tubau J. F., Ulep D., Bartels D. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. Ann Intern Med. 1987 Aug;107(2):150–157. doi: 10.7326/0003-4819-107-2-150. [DOI] [PubMed] [Google Scholar]
  16. Miller G. J., Miller N. E., Ashcroft M. T. Inverse relationship in Jamaica between plasma high-density lipoprotein cholesterol concentration and coronary-disease risk as predicted by multiple risk-factor status. Clin Sci Mol Med. 1976 Nov;51(5):475–482. doi: 10.1042/cs0510475. [DOI] [PubMed] [Google Scholar]
  17. Moser M., Lunn J. Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients. Angiology. 1981 Aug;32(8):561–566. doi: 10.1177/000331978103200806. [DOI] [PubMed] [Google Scholar]
  18. Pacy P. J., Dodson P. M., Beevers M., Fletcher R. F., Taylor K. G. The ethnic prevalence of hypertension in a diabetic clinic. Postgrad Med J. 1983 Oct;59(696):637–640. doi: 10.1136/pgmj.59.696.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Parving H. H., Andersen A. R., Smidt U. M., Svendsen P. A. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983 May 28;1(8335):1175–1179. doi: 10.1016/s0140-6736(83)92462-5. [DOI] [PubMed] [Google Scholar]
  20. Seedat Y. K. Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br Med J. 1980 Nov 8;281(6250):1241–1243. doi: 10.1136/bmj.281.6250.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Taguma Y., Kitamoto Y., Futaki G., Ueda H., Monma H., Ishizaki M., Takahashi H., Sekino H., Sasaki Y. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med. 1985 Dec 26;313(26):1617–1620. doi: 10.1056/NEJM198512263132601. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES